A comparative multi-centre study on the clinical and imaging features of comfirmed and uncomfirmed patients with COVID-19
Miao, C.; Zhuang, J.; Jin, M.; Xiong, H.; Huang, P.; Zhao, Q.; Miao, L.; Du, J.; Yang, X.; Huang, P.; Hong, J.
Show abstract
BackgroundPrevious studies had described the differences in clinical characteristics between ICU and non-ICU patients. However, seldom study focused on confirmed and unconfirmed groups. Our aim was to compare clinical and imaging characteristics of COVID-19 patients outside Hubei province between confirmed and unconfirmed group. MethodsWe retrospectively enrolled 163 consecutive adult patients with suspected COVID-19 from three tertiary hospitals in two provinces outside Hubei province from January 12, 2020 to February 13, 2020 and the differences in epidemiological, clinical, laboratory and imaging characteristics between the two groups were compared. ResultsThis study enrolled 163 patients with 62 confirmed cases and 101 unconfirmed cases. Most confirmed patients were clustered (31, 50.0%) and with definite epidemiological exposure. Symptoms of COVID-19 were nonspecific, largely fever and dry cough. Laboratory findings in confirmed group were characterized by normal or reduced white blood cell count, reduced the absolute value of lymphocytes, and elevated levels of C-reactive protein (CRP) and accelerated Erythrocyte sedimentation rate (ESR). The typical chest CT imaging features of patients with confirmed COVID-19 were peripherally distributed multifocal GGO with predominance in the lower lung lobe. Compared with unconfirmed patients, confirmed patients had significantly higher proportion of dry cough, leucopenia, lymphopenia and accelerated ESR (P<0.05); but not with alanine aminotransferase, aspartate aminotransferase, D-dimer, lactic dehydrogenase, and myoglobin (P>0.05). Proportion of peripheral, bilateral or lower lung distribution and multi-lobe involvement, GGO, crazy-paving pattern, air bronchogram and pleural thickening in the confirmed group were also higher (P<0.05). ConclusionsSymptoms of COVID-19 were nonspecific. Leukopenia, lymphopenia and ESR, as well as chest CT could be used as a clue for clinical diagnosis of COVID-19.
Matching journals
The top 7 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- Quantitative analysis of chest computed tomography of COVID-19 pneumonia using a software widely used in Japan 96%
- Assessing the impact of the Gamma variant on COVID-19 Patient admissions in a Southern Brazilian tertiary hospital - A comparison of dual pandemic phases 95%
- Characteristics and outcome profile of Hospitalized African COVID-19 patients: The Ethiopian Context 95%
Similar papers in this journal
- Evaluation of the disease outcome in Covid-19 infected patients by disease symptoms: a retrospective cross-sectional study in Ilam Province, Iran 95%
- Determinants of Developing Symptomatic Disease in Ethiopian COVID-19 Patients 93%
- Correlation Analysis Between Disease Severity and Inflammation-related Parameters in Patients with COVID-19 Pneumonia 93%
Similar papers in this journal
- Predictive validity of the simplified Radiographic Assessment of Lung Edema score for the mortality in critically ill COVID-19 patients with the B.1.617.2 (Delta) variant in Vietnam: a single-centre, cross-sectional study 97%
- Clinical findings in critical ill patients infected with SARS-Cov-2 in Guangdong Province, China: a multi-center, retrospective, observational study 95%
- Prognostic factors for COVID-19 pneumonia progression to severe symptom based on the earlier clinical features: a retrospective analysis 94%
Similar papers in this journal
- A Novel Triage Tool of Artificial Intelligence-Assisted Diagnosis Aid System for Suspected COVID-19 Pneumonia in Fever Clinics 95%
- Supportive Care for Patient with Respiratory Diseases: An Umbrella Review 94%
- Chest Computed Tomography for the Diagnosis of Patients with Coronavirus Disease 2019 (COVID-19): A Rapid Review and Meta-Analysis 92%
Similar papers in this journal
- Evaluation of rapid antibody test and chest computed tomography results of COVID-19 patients: A retrospective study 97%
- Relative expression of pro-inflammatory molecules in COVID-19 patients manifested disease severities 94%
- Risk factors for bacterial infections in patients with moderate to severe COVID-19: A case control study 94%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.